Treatment with TNF-inhibitors (TNF-i) is more promising in improving arthritis, enthesitis, dactylitis and skin, and presents a better efficacy in preventing joint destruction and radiographic progression with respect to therapy with conventional synthetic DMARDs [7]. This evidence concerns the gene TNF and Arthritis.